This inventor holds 1 USPTO granted patent. Top assignees: Arch Development Corporation, Health Research, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2007
Title: Innovations in Cancer Therapy by Richard L. Schilsky
Introduction
Richard L. Schilsky is a notable inventor based in La Grange, IL (US). He has made significant contributions to the field of cancer therapy, particularly through his innovative approaches to treating cancers characterized by the overexpression of the HER2 receptor protein. His work has the potential to improve therapeutic responses in patients suffering from these aggressive forms of cancer.
Latest Patents
Richard L. Schilsky holds a patent for "Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein." This patent outlines methods for treating subjects with cancer that overexpresses the HER2 receptor protein. The innovative approach involves using a combination of interleukin-2 (IL-2) or its variants alongside at least one anti-HER2 antibody or fragment thereof. These anti-tumor agents are administered as two separate pharmaceutical compositions, enhancing the effectiveness of the anti-HER2 antibody and resulting in improved therapeutic responses. He has 1 patent to his name.
Career Highlights
Throughout his career, Richard has worked with various organizations, including Health Research, Inc. and Arch Development Corporation. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to advancements in cancer treatment.
Collaborations
Richard has collaborated with notable professionals such as Michael A. Caligiuri and Neal J. Meropol. These partnerships have further enriched his research and development efforts in cancer therapies.
Conclusion
Richard L. Schilsky's innovative work in cancer therapy exemplifies the impact of targeted treatments on patient outcomes. His contributions continue to pave the way for advancements in the medical field, particularly in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile